LOXONIN

This brand name is authorized in Brazil, Japan, Mexico

Active ingredients

The drug LOXONIN contains one active pharmaceutical ingredient (API):

1 Loxoprofen
UNII NDC2M7399S - LOXOPROFEN SODIUM

Loxoprofen has excellent analgesic, anti-inflammatory and antipyretic properties, with particularly potent pain-relieving activity. This drug is a prodrug which is biotransformed into an active metabolite trans-OH form (SRS coordination) to exert its actions. Inhibition of prostaglandin biosynthesis constitutes the mechanism of action of loxoprofen, the site of action being cyclo-oxygenase.

Read about Loxoprofen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M02AA31 M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA31

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 530401003111313, 530401004116319, 530401006119315, 530420070015707, 530420070015807, 530420070015907, 530420070016007, 530420070016107, 530420070016207
Country: JP 医薬品医療機器総合機構 Identifier(s): 1149019C1149, 1149019F1560, 2649735Q1020, 2649735S1028, 2649735S2024, 2649735S3020
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 194M2001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.